102 related articles for article (PubMed ID: 20356671)
21. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
22. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
[TBL] [Abstract][Full Text] [Related]
23. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH
J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription.
Somasundaram K
J Cell Biochem; 2003 Apr; 88(6):1084-91. PubMed ID: 12647291
[TBL] [Abstract][Full Text] [Related]
25. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1.
Southey MC; Tesoriero A; Young MA; Holloway AJ; Jenkins MA; Whitty J; Misfud S; kConFab ; McLachlan SA; Venter DJ; Armes JE
Hum Mutat; 2003 Jul; 22(1):86-91. PubMed ID: 12815598
[TBL] [Abstract][Full Text] [Related]
26. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis by the tumor suppressor protein BRCA1.
Shao N; Chai YL; Shyam E; Reddy P; Rao VN
Oncogene; 1996 Jul; 13(1):1-7. PubMed ID: 8700535
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
[TBL] [Abstract][Full Text] [Related]
29. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
[TBL] [Abstract][Full Text] [Related]
30. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
31. Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.
Ansquer Y; Legrand A; Bringuier AF; Vadrot N; Lardeux B; Mandelbrot L; Feldmann G
Anticancer Res; 2005; 25(1A):243-8. PubMed ID: 15816544
[TBL] [Abstract][Full Text] [Related]
32. Implication of BRCA1 gene in breast cancer.
Kachhap SK; Ghosh SN
Indian J Exp Biol; 2001 May; 39(5):391-400. PubMed ID: 11510120
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the BRCA1 gene in human cancer.
Xu CF; Solomon E
Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
[TBL] [Abstract][Full Text] [Related]
34. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
35. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
Yuli C; Shao N; Rao R; Aysola P; Reddy V; Oprea-llies G; Lee L; Okoli J; Partridge E; Reddy ES; Rao VN
Oncogene; 2007 Sep; 26(41):6031-7. PubMed ID: 17384678
[TBL] [Abstract][Full Text] [Related]
36. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer.
Okumura N; Yoshida H; Kitagishi Y; Nishimura Y; Matsuda S
Biochem Biophys Res Commun; 2011 Sep; 413(3):395-9. PubMed ID: 21893034
[TBL] [Abstract][Full Text] [Related]
38. Mapping and conformational characterization of the DNA-binding region of the breast cancer susceptibility protein BRCA1.
Naseem R; Sturdy A; Finch D; Jowitt T; Webb M
Biochem J; 2006 May; 395(3):529-35. PubMed ID: 16460311
[TBL] [Abstract][Full Text] [Related]
39. A new alternative splice variant of BRCA1 containing an additional in-frame exon.
Fortin J; Moisan AM; Dumont M; Leblanc G; Labrie Y; Durocher F; Bessette P; Bridge P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Provencher L; Voyer P; Simard J
Biochim Biophys Acta; 2005 Oct; 1731(1):57-65. PubMed ID: 16185777
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220.
Wada O; Oishi H; Takada I; Yanagisawa J; Yano T; Kato S
Oncogene; 2004 Aug; 23(35):6000-5. PubMed ID: 15208681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
